Enantiomeric Separation of Tramadol and Its Metabolites: Method Validation and Application to Environmental Samples
暂无分享,去创建一个
Cátia Silva | Cláudia Ribeiro | Alexandra S. Maia | Virgínia Gonçalves | Maria Elizabeth Tiritan | Carlos M. M. Afonso | C. Ribeiro | M. Tiritan | A. Maia | V. Gonçalves | C. Afonso | Cátia Silva
[1] F. Musshoff,et al. Fatality due to ingestion of tramadol alone. , 2001, Forensic science international.
[2] Alejandro J. Ramirez,et al. Enantiospecific toxicity of the β‐blocker propranolol to Daphnia magna and Pimephales promelas , 2006, Environmental toxicology and chemistry.
[3] D. Muntean,et al. Optimized HPLC method for tramadol and O-desmethyl tramadol determination in human plasma. , 2008, Journal of biochemical and biophysical methods.
[4] A. Lubben,et al. Enantiomeric profiling of chiral drug biomarkers in wastewater with the usage of chiral liquid chromatography coupled with tandem mass spectrometry. , 2016, Journal of chromatography. A.
[5] A. Foroumadi,et al. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] A. Foroumadi,et al. Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[7] P. Shrivastav,et al. An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS. , 2009, Journal of pharmaceutical and biomedical analysis.
[8] H. El-Abhar,et al. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. , 2002, Journal of ethnopharmacology.
[9] P. Chiap,et al. Automated determination of tramadol enantiomers in human plasma using solid-phase extraction in combination with chiral liquid chromatography. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[10] M. Schmid,et al. Chiral separation of cathinone derivatives used as recreational drugs by HPLC-UV using a CHIRALPAK® AS-H column as stationary phase. , 2012, Chirality.
[11] J. Haginaka. Recent progresses in protein-based chiral stationary phases for enantioseparations in liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] G. Scriba. Chiral Recognition Mechanisms in Analytical Separation Sciences , 2012, Chromatographia.
[13] H. Dengler,et al. PHARMACOKINETICS AND DISPOSITION , 1997 .
[14] R. Raffa,et al. Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[15] S. Evans,et al. Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry. , 2015, Analytica chimica acta.
[16] T. C. Lourenço,et al. Fases estacionárias quirais para cromatografia líquida de alta eficiência , 2010 .
[17] P. Castro,et al. Chiral pharmaceuticals in the environment , 2012, Environmental Chemistry Letters.
[18] S. Grond,et al. Clinical Pharmacology of Tramadol , 2004, Clinical pharmacokinetics.
[19] D. Massart,et al. Screening approach for chiral separation of pharmaceuticals. Part I. Normal-phase liquid chromatography. , 2002, Journal of chromatography. A.
[20] R. Mehvar,et al. Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] F. Carvalho,et al. Simultaneous quantification of tramadol and O-desmethyltramadol in hair samples by gas chromatography-electron impact/mass spectrometry. , 2013, Biomedical chromatography : BMC.
[22] F. Musshoff,et al. Enantiomeric determination of tramadol and O-desmethyltramadol by liquid chromatography- mass spectrometry and application to postoperative patients receiving tramadol. , 2006, Journal of analytical toxicology.
[23] R. Calvo,et al. Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[24] L. Vlase,et al. Determination of tramadol and O-desmethyltramadol in human plasma by high-performance liquid chromatography with mass spectrometry detection. , 2008, Talanta.
[25] A. Hoeft,et al. Concentrations of Tramadol and O‐desmethyltramadol Enantiomers in Different CYP2D6 Genotypes , 2007, Clinical pharmacology and therapeutics.
[26] M. Pinto,et al. Small Molecules as Chromatographic Tools for HPLC Enantiomeric Resolution: Pirkle-Type Chiral Stationary Phases Evolution , 2013, Chromatographia.
[27] S. Gan,et al. Validation of a high-performance liquid chromatography method for tramadol and o-desmethyltramadol in human plasma using solid-phase extraction. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[28] T. Ward,et al. Chiral separations: fundamental review 2010. , 2010, Analytical chemistry.
[29] P. Castro,et al. Environmental Fate of Chiral Pharmaceuticals: Determination, Degradation and Toxicity , 2012 .
[30] Qin Li,et al. Simultaneous analysis of tramadol, metoprolol and their metabolites in human plasma and urine by high performance liquid chromatography , 2006, Chinese medical journal.
[31] J. Roeraade,et al. Evaluation of generic chiral liquid chromatography screens for pharmaceutical analysis. , 2003, Journal of chromatography. A.
[32] V. Sharma,et al. Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk , 2015, Environmental Chemistry Letters.
[33] M. Rouini,et al. Improved liquid chromatographic method for the simultaneous determination of tramadol and its three main metabolites in human plasma, urine and saliva. , 2007, Journal of pharmaceutical and biomedical analysis.
[34] S. Fanali,et al. Simultaneous stereoselective analysis of tramadol and its main phase I metabolites by on-line capillary zone electrophoresis-electrospray ionization mass spectrometry. , 2000, Journal of chromatography. A.
[35] Alejandro J. Ramirez,et al. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. , 2007, Chemosphere.
[36] Y. Heyden,et al. Screening approach for chiral separation of pharmaceuticals part II. Reversed-phase liquid chromatography. , 2002, Journal of chromatography. A.
[37] Zhongqi Ren,et al. Chiral liquid membrane for enantioselective separation of racemic ibuprofen by L-tartaric acid derivatives , 2015 .
[38] Q. Cass,et al. Enantiomeric resolution of a series of chiral sulfoxides by high-performance liquid chromatography on polysaccharide-based columns with multimodal elution. , 2003, Journal of chromatography. A.
[39] A. R. Ribeiro,et al. Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: an overview. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[40] O. Matoušková,et al. Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[41] M. Nobilis,et al. High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma. Application to a bioequivalence study in humans. , 2002, Journal of chromatography. A.
[42] I. Rukhlenko,et al. Completely Chiral Optical Force for Enantioseparation , 2016, Scientific Reports.
[43] G. Szekely,et al. Role of chirality and macroring in imprinted polymers with enantiodiscriminative power. , 2015, ACS applied materials & interfaces.
[44] E. Tesařová,et al. Recentchiral selectors for separation in HPLC and CE , 2012 .
[45] E. Shipton,et al. Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years--a pilot study. , 2002, Anesthesia progress.
[46] F. Wong,et al. The determination of RWJ-38705 (tramadol N-oxide) and its metabolites in preclinical pharmacokinetic studies using LC-MS/MS. , 2000, Journal of pharmaceutical and biomedical analysis.
[47] J. P. Fawcett,et al. Improved HPLC method for the simultaneous determination of tramadol and O-desmethyltramadol in human plasma. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[48] M. A. Campanero,et al. Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography. Application to a pharmacokinetic study in humans. , 2004, Journal of chromatography. A.
[49] A. Ceccato,et al. Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[50] A. Palmeira,et al. Enantioresolution of chiral derivatives of xanthones on (S,S)-Whelk-O1 and L-phenylglycine stationary phases and chiral recognition mechanism by docking approach for (S,S)-Whelk-O1. , 2013, Chirality.
[51] I. Moreira,et al. Enantioselective quantification of fluoxetine and norfluoxetine by HPLC in wastewater effluents. , 2014, Chemosphere.
[52] D. Holt,et al. Simultaneous determination of tramadol, O-desmethyltramadol and N-desmethyltramadol in human urine by gas chromatography-mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[53] E. Awadalla,et al. Histopathological and Molecular Studies on Tramadol Mediated Hepato-Renal Toxicity in Rats , 2015 .
[54] M. Lämmerhofer. Chiral recognition by enantioselective liquid chromatography: mechanisms and modern chiral stationary phases. , 2010, Journal of chromatography. A.
[55] K. Kümmerer,et al. The significance of different health institutions and their respective contributions of active pharmaceutical ingredients to wastewater. , 2015, Environment international.
[56] Y. Heyden,et al. Screening approach for chiral separation of pharmaceuticals , 2002 .